EBOS GROUP LIMITED — M&A Activity 2021

Sep 1, 2021

==> picture [144 x 42] intentionally omitted <==

1 September 2021

NZX/ASX Code: EBO

EBOS expands further into medical consumables with the acquisition of Sentry Medical

EBOS Group Limited (EBOS) is pleased to announce that it has completed the acquisition of Sentry Medical.

Sentry Medical is a designer, marketer and distributor of a broad range of medical consumable products, including its own brands and agency brands. Sentry is based in Australia and supplies to customers including wholesalers, hospitals, general practitioners, dental surgeries, aged care facilities, pharmacies, government agencies and vet clinics.

On 18 August 2021, along with the release of its FY21 financial results, EBOS announced that it had a high degree of confidence of executing an acquisition within its Institutional Healthcare division within the near term. Sentry Medical is the acquisition referred to.

Sentry Medical will further strengthen EBOS’ presence in the distribution of medical consumables to the institutional healthcare market, which is a growing business for EBOS.

This is EBOS’ fourth acquisition completed during the last 12 months and represents a continuation of our strategy of investing for growth.

For further information please contact:

Martin Krauskopf General Manager, Mergers & Acquisitions and Investor Relations +61 3 9918 5555

Authorised for lodgement with NZX and ASX by Janelle Cain, General Counsel, EBOS Group Limited.

About EBOS Group

EBOS Group Limited NZBN 9429031998840 (NZX/ASX Code: EBO) is the largest and most diversified Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. It is also a leading Australasian animal care brand owner, product marketer and distributor.